Medication-related osteonecrosis of the jaws associated with intravitreal administration of ranibizumab
We report a case of MRONJ after intravitreal injection of a different anti-angiogenic agent – ranibizumab – for the treatment o f neovascular age-related macular degeneration, in a bisphosphonate-naïve patient.
Source: International Journal of Oral and Maxillofacial Surgery - Category: ENT & OMF Authors: I. Oz, I. Kaplan, S. Kleinman, S. Arbel, A. Shuster Tags: Case Report Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Avastin | ENT & OMF | Lucentis | Ranibizumab Injection